Episurf Medical AB to present at ProHearings investor meeting in Stockholm, June 3

Episurf Medical AB will present at ProHearings investor meeting in Stockholm on June 3. The company will be represented by CFO Pål Ryfors and COO Jeanette Spångberg.  For full program and registration, see link: http://www.prohearings.com/.

For more information, please contact:

Pål Ryfors, CFO, Episurf Medical

Tel: +46 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention.

Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. The information in this press release is such that Episurf Medical AB is required to disclose in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act.